Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab
暂无分享,去创建一个
Y. Young-Xu | R. Melsheimer | P. Lefebvre | R. Bhak | B. Emond | C. Nguyen | A. Lax | I. Lin | I. Lin | Melody Wu | M. DerSarkissian